Ashwath Jayagopal's most recent trade in Opus Genetics Inc. was a trade of 52,500 Common Stock done . Disclosure was reported to the exchange on March 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | Ashwath Jayagopal | Chief Scientific & Dev. Ofc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 52,500 | 125,807 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Ashwath Jayagopal | Chief Scientific & Dev. Ofc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 52,500 | 52,500 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Ashwath Jayagopal | Chief Scientific & Dev. Ofc. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 13 Feb 2025 | 5,193 | 73,307 | - | 1.2 | 5,972 | Common Stock |
| Opus Genetics Inc. | Ashwath Jayagopal | Chief Scientific & Dev. Ofc. | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 22 May 2024 | 3,500 | 78,500 | - | 1.8 | 6,178 | Common Stock |
| Opus Genetics Inc. | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 225,000 | 225,000 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 75,000 | 75,000 | - | 0 | Common Stock |